Nimotop

Nimodipine

This medication is indicated for neurological recovery after subarachnoid haemorrhage utilized to mitigate vasospasm and support brain cell protection.

Active ingredient
Nimodipine
Supply
Pharmacy
Route
Oral use
Form
Film-coated tablet
Strengths
30mg

Nimotop details

Therapeutic class
Calcium Channel Blocker
Pharmacological class
Dihydropyridine Calcium Channel Blocker
Contraindications
hypersensitivity to nimodipine; concomitant use of rifampicin
Precautions and warnings
may impair ability to drive or operate machinery; monitor blood pressure
Minor side effects
headache; flushing
Moderate side effects
hypotension; nausea; dizziness
Dosage forms
Film-coated tablet
Administration route
Oral use
Supply category
Pharmacist only, dispensed without a prescription
Manufacturer
Bayer
Onset Time
1–2 hours
Duration
4–6 hours
Storage instructions
Store below 30°C in the original container.
Drug interactions
Grapefruit; Anticonvulsants
Age restrictions
Not for children.
Pregnancy and breastfeeding
Pregnancy: Do not use. Breastfeeding: Not recommended.
Serious side effects

severe hypotension, requires immediate medical attention; bradycardia, requires immediate medical attention

Patient summary

This medication is indicated for neurological recovery after subarachnoid haemorrhage utilized to mitigate vasospasm and support brain cell protection.

Mechanism of action

Nimodipine is a calcium antagonist that preferentially dilates cerebral blood vessels by preventing the influx of calcium ions into vascular smooth muscle cells.

Where this medicine is registered

  • Singapore
  • Hong Kong
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Taiwan
  • South Korea
  • Japan
  • Australia
  • New Zealand
  • UAE
  • South Africa

About Nimotop

Nimotop is a pharmaceutical treatment from Bayer containing the active ingredient Nimodipine. It is designed to manage the neurological effects that can follow a subarachnoid haemorrhage. This medication is supplied as a 30mg tablet, providing a specific therapeutic formulation for patient care.

Buying Nimotop online

Nimotop is registered across 14 markets globally, including Malaysia, the Philippines and Indonesia, with availability also in Taiwan, South Korea and Japan. While generic versions of Nimodipine, often made in India, are more affordable than the original brand, many patients prefer the quality and consistency of the Bayer product. Nimotop is one of the most ordered treatments across the region, accessible online for delivery to your location, providing a straightforward solution for expats and residents living far from a fully stocked pharmacy.